M&A Deal Summary

Khiron Life Sciences Acquires Pharmadrug Production

On August 2, 2022, Khiron Life Sciences acquired medical products company Pharmadrug Production from Pharmadrug

Acquisition Highlights
  • This is Khiron Life Sciences’ 1st transaction in the Medical Products sector.
  • This is Khiron Life Sciences’ 1st transaction in Germany.

M&A Deal Summary

Date 2022-08-02
Target Pharmadrug Production
Sector Medical Products
Buyer(s) Khiron Life Sciences
Sellers(s) Pharmadrug
Deal Type Divestiture

Target

Pharmadrug Production

Hamburg, Germany
Pharmadrug Production is a generic pharmaceutical manufacturer specialized in supplying finished dosage forms (FDFs), active pharmaceutical ingredients (APIs) and other healthcare products. Pharmadrug Production is based in Hamburg, Germany.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Khiron Life Sciences

Toronto, Ontario, Canada

Category Company
Founded 2017
Sector Consumer Products
Revenue 13M CAD (2021)
DESCRIPTION

Khiron Life Sciences is positioned to be the dominant integrated cannabis company. Khiron has core operations in Latin America and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. Khiron Life Sciences was founded in 2017 and is based in Toronto, Ontario.


DEAL STATS #
Overall 3 of 3
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-25 Canapalife Srl

Padova, Italy

Canapalife Srl is a producer and processor of hemp products in Italy and engages in the research and development of new hemp food ingredients. The company collaborates with universities, research institutes, and organizations from the food, materials, pharmaceutical and cosmetics industries.

Buy -

Seller(S) 1

SELLER

Pharmadrug

Toronto, Ontario, Canada

Category Company
Sector Consumer Products
DESCRIPTION

Pharmadrug is building an international network of vertically integrated cannabis assets. Through an established product line of cannabis-infused edible products and oil extracts. Pharmadrug is based in Toronto, Ontario.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-25 Pharmadrug Production

Hamburg, Germany

Pharmadrug Production is a generic pharmaceutical manufacturer specialized in supplying finished dosage forms (FDFs), active pharmaceutical ingredients (APIs) and other healthcare products. Pharmadrug Production is based in Hamburg, Germany.

Buy €5M